Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSyncona Regulatory News (SYNC)

Share Price Information for Syncona (SYNC)

Share Price is delayed by 15 minutes
Get Live Data
99.90    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 1.30 (1.312%)
Market Cap: £607.58m
SYNC Live PriceLast checked at - London Stock Exchange

Intraday Syncona Share Chart

Director/PDMR Shareholding

27 Mar 2019 11:12

RNS Number : 1827U
Syncona Limited
27 March 2019
 

Syncona Limited

Notification of Transactions by Persons Discharging Managerial Responsibilities ("PDMRs") and Connected Persons

 

27 March 2019

 

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Nicholas Moss

b)

Position / status

Senior Independent Director

c)

Initial notification / amendment

Initial Notification

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary shares

GG00B8P59C08

 

b)

Nature of the transaction

Purchase of shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

2.497

8,004

d)

Aggregated information

Aggregated volume

Price

 N/A

e)

Date of the transaction

22 March 2019

f)

Place of the transaction

London Stock Exchange

g)

Currency

GBP - British Pound

 

 

[ENDS]

 

Enquiries

Syncona Ltd

Annabel Clay

Tel: +44 (0) 20 7611 2031

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHUBRARKKAOUAR
Date   Source Headline
19th Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20247:00 amRNSTransaction in Own Shares
15th Mar 20247:00 amRNSTransaction in Own Shares
14th Mar 202411:05 amRNSAutolus reports full year 2023 Financial Results
14th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 20247:00 amRNSTransaction in Own Shares
11th Mar 20247:00 amRNSTransaction in Own Shares
8th Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 20247:00 amRNSTransaction in Own Shares
6th Mar 20245:22 pmRNSDirector Declaration
6th Mar 20247:00 amRNSTransaction in Own Shares
4th Mar 20247:00 amRNSTransaction in Own Shares
1st Mar 20241:30 pmRNSTotal Voting Rights
22nd Feb 20247:00 amRNSTransaction in Own Shares
21st Feb 20247:00 amRNSTransaction in Own Shares
20th Feb 202412:02 pmRNSAcquisition of Freeline Becomes Effective
20th Feb 20247:00 amRNSTransaction in Own Shares
19th Feb 20247:00 amRNSTransaction in Own Shares
16th Feb 20247:00 amRNSTransaction in Own Shares
15th Feb 20247:00 amRNSTransaction in Own Shares
14th Feb 20247:00 amRNSTransaction in Own Shares
13th Feb 20247:00 amRNSTransaction in Own Shares
9th Feb 20247:00 amRNSTransaction in Own Shares
8th Feb 202412:53 pmRNSAutolus offering (Amendment)
8th Feb 202412:13 pmRNSAutolus announces pricing of public offering
8th Feb 202412:05 pmRNSBeacon presents 12-month clinical data
8th Feb 202410:50 amRNSAutolus announces Strategic Collaboration
8th Feb 20247:00 amRNSThird Quarter Update
8th Feb 20247:00 amRNSTransaction in Own Shares
7th Feb 20247:00 amRNSTransaction in Own Shares
6th Feb 20247:00 amRNSTransaction in Own Shares
5th Feb 20247:00 amRNSTransaction in Own Shares
2nd Feb 20247:00 amRNSTransaction in Own Shares
1st Feb 20242:02 pmRNSTotal Voting Rights
1st Feb 20247:00 amRNSTransaction in Own Shares
31st Jan 20247:00 amRNSTransaction in Own Shares
30th Jan 20247:00 amRNSTransaction in Own Shares
29th Jan 20247:00 amRNSTransaction in Own Shares
26th Jan 20247:00 amRNSTransaction in Own Shares
25th Jan 20247:00 amRNSTransaction in Own Shares
24th Jan 20247:00 amRNSTransaction in Own Shares
23rd Jan 20247:00 amRNSTransaction in Own Shares
22nd Jan 202412:05 pmRNSAutolus announces acceptance of BLA for obe-cel
22nd Jan 20247:00 amRNSTransaction in Own Shares
19th Jan 20247:00 amRNSFreeline announces further data
18th Jan 20247:00 amRNSTransaction in Own Shares
17th Jan 20247:00 amRNSTransaction in Own Shares
16th Jan 20247:00 amRNSTransaction in Own Shares
15th Jan 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.